Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William H Eger

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Research Square|August 16, 2024
Protective or potentially harmful? Altering drug consumption behaviors in response to xylazine adulterationWilliam H Eger, Marina Plesons, Tyler S Bartholomew, et al.
The International Journal on Drug Policy|July 24, 2025
Modeling the impact of changing drug markets and structural determinants on HCV and/or HIV transmission among people who inject drugs in the United States: A rural and urban comparisonNatasha K Martin, Daniela Abramovitz, William H Eger, et al.
Drug and Alcohol Dependence Reports|July 21, 2025
Psychosocial consequences of xylazine and implications for harm reduction servicesMarina Plesons, William H Eger, Erika L Crable, et al.
The International Journal on Drug Policy|September 15, 2024
A mixed methods study to inform fatal overdose prevention in San Diego, California: Perspectives from people who use drugsKatie Bailey, Arielle Schecter, William H Eger, et al.
Addiction Science & Clinical Practice|April 6, 2026
Implementation of low-dose buprenorphine induction at a syringe services programMaia H Hauschild, Peyton V Warp, William H Eger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 30, 2024
Illicit Fentanyl Use and Hepatitis C Virus Seroconversion Among People Who Inject Drugs in Tijuana and San Diego: Results From a Binational Cohort StudyJoseph R Friedman, Daniela Abramovitz, Britt Skaathun, et al.
Harm Reduction Journal|February 4, 2024
Health, harm reduction, and social service providers' perspectives on the appropriateness and feasibility of peer distribution of HIV self-test kits among people who use drugsAngela R Bazzi, Chad J Valasek, Tara Stamos-Buesig, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Research Square|August 16, 2024
Protective or potentially harmful? Altering drug consumption behaviors in response to xylazine adulterationWilliam H Eger, Marina Plesons, Tyler S Bartholomew, et al.
The International Journal on Drug Policy|July 24, 2025
Modeling the impact of changing drug markets and structural determinants on HCV and/or HIV transmission among people who inject drugs in the United States: A rural and urban comparisonNatasha K Martin, Daniela Abramovitz, William H Eger, et al.
Drug and Alcohol Dependence Reports|July 21, 2025
Psychosocial consequences of xylazine and implications for harm reduction servicesMarina Plesons, William H Eger, Erika L Crable, et al.
The International Journal on Drug Policy|September 15, 2024
A mixed methods study to inform fatal overdose prevention in San Diego, California: Perspectives from people who use drugsKatie Bailey, Arielle Schecter, William H Eger, et al.
Addiction Science & Clinical Practice|April 6, 2026
Implementation of low-dose buprenorphine induction at a syringe services programMaia H Hauschild, Peyton V Warp, William H Eger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 30, 2024
Illicit Fentanyl Use and Hepatitis C Virus Seroconversion Among People Who Inject Drugs in Tijuana and San Diego: Results From a Binational Cohort StudyJoseph R Friedman, Daniela Abramovitz, Britt Skaathun, et al.
Harm Reduction Journal|February 4, 2024
Health, harm reduction, and social service providers' perspectives on the appropriateness and feasibility of peer distribution of HIV self-test kits among people who use drugsAngela R Bazzi, Chad J Valasek, Tara Stamos-Buesig, et al.
Pageof 3